John Hawley

The 2019 Stanley J. Korsmeyer Award: Michael S. Diamond, MD, PhD

Posted on by John Hawley

Dr. Diamond

Michael S. Diamond, MD, PhD, is the recipient of the American Society for Clinical Investigation’s (ASCI) 2019 Stanley J. Korsmeyer Award for his key contributions to understanding the molecular basis of disease caused by globally emerging RNA viruses.

Dr. Diamond received his BA from Columbia University in 1985, his PhD from Harvard University in 1992 in the laboratory of Timothy A. Springer, PhD, and his MD from Harvard Medical School in 1994. From 1994 to 1995 he was a postdoctoral fellow in the laboratory of Gerald M. Rubin, PhD, Department of Genetics, University of California, Berkeley; and from 1998 to 2001 he was a postdoctoral fellow in the laboratory of Eva Harris, PhD, Department of Public Health, University of California, Berkeley.

An RNA virus has RNA, as opposed to DNA, as its genetic material. As a result, RNA viruses in general have a higher mutation rate than DNA viruses, complicating efforts to produce vaccines to reduce or prevent infection. Dr. Diamond has focused on a subset of RNA viruses known as flaviviruses, which include Zika, West Nile, and dengue viruses, and alphaviruses, which include chikungunya virus. Dr. Diamond has identified many of the key immune system components that define host protection against these virus types, and the viral genes that work against this response.

In 2010, his laboratory made a seminal discovery by identifying a novel pathogen-associated molecular pattern (lack of 2′-O-methylation on the 5′ viral RNA cap) and mechanism of innate immune restriction through IFIT1 proteins. His group has used genome-wide screening to identify host factors required by viruses, including Mxra8, a novel entry receptor for multiple alphaviruses of global concern. He has led the field in studying mechanisms of pathogenesis of Zika infection and disease, including in pregnancy. His group also has generated, characterized, and mapped thousands of neutralizing antibodies against Zika, West Nile, dengue, chikungunya, and other viruses. His work has led directly to the development of therapeutic antibodies and vaccines against both flaviviruses and alphaviruses.

Dr. Diamond joined the Washington University School of Medicine in St. Louis in 2001. He is currently the Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, and Pathology & Immunology, and Associate Director, Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine. An active mentor, he has 7 doctoral students at present and has advised 14 who have completed their PhD degrees in his laboratory; he currently has 7 postdoctoral fellows and has mentored more than 20 in his group who have transitioned to independent careers in academia and industry.

Dr. Diamond’s research has been supported by the U.S. National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the National Institute of Neurological Disorders and Stroke.

Dr. Diamond was a recipient of the Edward Mallinckrodt, Jr. Foundation Award (2002-2004), a New Scholar Award in Global Infectious Disease, Ellison Medical Foundation (2003-2006), and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (2007-2015). He was elected as an ASCI member in 2007; an American Academy of Microbiology Fellow in 2010; an Association of American Physicians member in 2011; an American Association for the Advancement of Science Fellow in 2017; and a National Academy of Medicine member in 2018.

New members, 2019

Posted on by John Hawley

On behalf of the ASCI Council, I am pleased to announce the election of the Society’s new members for 2019.

These new members come from 46 different institutions and represent excellence across the breadth of academic medicine. They will be officially inducted into the Society at the ASCI Dinner & New Member Induction Ceremony on April 5, 2019, as part of the 2019 AAP/ASCI/APSA Joint Meeting (April 5-7) at the Fairmont Chicago Millennium Park. We hope you will be able to join us.

The Council recommended 80 nominees (the limit according to the ASCI bylaws) for election from the 176 nominations submitted for consideration. The Active segment of the membership recently voted to confirm the recommendation, with over 60% of eligible voters submitting their votes by the December 5 deadline. The vote was overwhelmingly in favor of approving the recommendation.

As Secretary-Treasurer, I served as one of three required auditors of the ballot. Thank you to Benjamin Humphreys and XinQi Dong, who volunteered their time to serve as the other two auditors.

Sincerely,

Hossein Ardehali, MD, PhD
2017-2019 Secretary-Treasurer
The American Society for Clinical Investigation

Name Institution
Kjersti M. Aagaard, MD, PhD Baylor College of Medicine
Michelle Asha Albert, MD, MPH University of California, San Francisco, School of Medicine
Laura Cristina Alonso, MD University of Massachusetts Medical School
Joshi J. Alumkal, MD Oregon Health & Science University
Jintanat Ananworanich, MD, PhD U.S. Military HIV Research Program (MHRP)
Reza Ardehali, MD, PhD University of California, Los Angeles, David Geffen School of Medicine
Maryam M. Asgari, MD, MPH Harvard Medical School, Massachusetts General Hospital
David Allen Barbie, MD Harvard Medical School, Dana-Farber Cancer Institute
Gregory Lawrence Beatty, MD, PhD University of Pennsylvania School of Medicine
Eran Bendavid, MD, MS Stanford University School of Medicine
Rachel Pardes Berger, MD, MPH University of Pittsburgh Children’s Hospital
Chetan Bettegowda, MD, PhD Johns Hopkins University School of Medicine
Ankit Bharat, MBBS Northwestern University Feinberg School of Medicine
Bibiana Bielekova, MD NIH, National Institute of Allergy and Infectious Diseases
Marie Bleakley, MD, PhD, MClinEpi University of Washington School of Medicine
Barry A. Borlaug, MD Mayo Clinic
Isaac F. Brownell, MD, PhD NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Carolyn S. Calfee, MD, MAS University of California, San Francisco, School of Medicine
Marina Caskey, MD The Rockefeller University
Ronald C. Chen, MD, MPH University of North Carolina at Chapel Hill
Stuart Alexander Cook, BsC, MBBS, MRCP, PhD Duke-NUS Medical School
Kelly E. Dooley, MD, PhD, MPH Johns Hopkins University School of Medicine
Todd E. Druley, MD, PhD Washington University School of Medicine in St. Louis
Kafui Dzirasa, MD, PhD Duke University Medical Center
Souheil Youssef El-Chemaly, MD, MPH Harvard Medical School, Brigham & Women’s Hospital
Felix Y. Feng, MD University of California, San Francisco, School of Medicine
Michael David Fox, MD, PhD Harvard Medical School, Beth Israel Deaconess Medical Center
Saar I. Gill, MD, PhD University of Pennsylvania School of Medicine
Morgan E. Grams, MD, PhD, MHS Johns Hopkins University School of Medicine
Peter W. Groeneveld, MD, MS University of Pennsylvania School of Medicine
Orlando M. Gutierrez, MD, MMSc University of Alabama at Birmingham School of Medicine
Jason B. Harris, MD, MPH Harvard Medical School, Massachusetts General Hospital
John E. Harris, MD, PhD University of Massachusetts Medical School
Elliott Richard Haut, MD, PhD Johns Hopkins University School of Medicine
Anna Ryan Hemnes, MD Vanderbilt University School of Medicine
A. McGarry Houghton, MD Fred Hutchinson Cancer Research Center
Renee Yuen-Jan Hsia, MD, MSc University of California, San Francisco, School of Medicine
David Michael Hyman, MD Memorial Sloan Kettering Cancer Center
Louise C. Ivers, MD, MPH Harvard Medical School, Massachusetts General Hospital
William J. Janssen, MD National Jewish Health
Jonathan James Juliano, MD, MSPH, DTM&H University of North Carolina at Chapel Hill
Dineo Khabele, MD, FACOG, FACS University of Kansas School of Medicine
Richard Glenn Kibbey IV, MD, PhD Yale School of Medicine
Amy J.H. Kind, MD, PhD University of Wisconsin Medical School
Heidi H. Kong, MD, MHSc NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Scott Kopetz, MD, PhD University of Texas M.D. Anderson Cancer Center
Siavash K. Kurdistani, MD University of California, Los Angeles, David Geffen School of Medicine
Louise Chang Laurent, MD, PhD University of California, San Diego, School of Medicine
Julie E. Ledgerwood, DO NIH, National Institute of Allergy and Infectious Diseases
Alexander Marson, MD, PhD University of California, San Francisco, School of Medicine
Samia Mora, MD, MHS Harvard Medical School, Brigham & Women’s Hospital
Nima Mosammaparast, MD, PhD Washington University School of Medicine in St. Louis
Nicolas Musi, MD University of Texas Health Science Center at San Antonio
Markus Müschen, MD, PhD City of Hope Medical Center
Keisuke Nagao, MD, PhD NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Serge Patrick Nana-Sinkam, MD Virginia Commonwealth University School of Medicine
Dale Murray Needham, MD, PhD Johns Hopkins Medical Institutes
Sattva S. Neelapu, MD University of Texas M.D. Anderson Cancer Center
Deepak Nijhawan, MD, PhD University of Texas Southwestern Medical Center
Emily Oken, MD, MPH Harvard Medical School
Elif Arioglu Oral, MD University of Michigan Medical School
Brian A. Primack, MD, PhD, MS, EdM University of Pittsburgh School of Medicine
Jianwen Que, MD, PhD Columbia University College of Physicians & Surgeons
Manuela Raffatellu, MD University of California, San Diego, School of Medicine
Peter Philip Reese, MD, MSCE University of Pennsylvania School of Medicine
Erik D. Roberson, MD, PhD University of Alabama at Birmingham School of Medicine
Andrew David Rule, MD, MSc Mayo Clinic
Aasma Shaukat, MD, MPH University of Minnesota Medical School
Jordan A. Shavit, MD, PhD University of Michigan Medical School
Maureen A. Su, MD University of California, Los Angeles, David Geffen School of Medicine
Yang Sun, MD, PhD Stanford University School of Medicine
William Douglas Tap, MD Memorial Sloan Kettering Cancer Center
Robert Thimme, MD University Medical Center Freiburg
Aaron A. R. Tobian, MD, PhD Johns Hopkins University School of Medicine
Eliezer M. Van Allen, MD Harvard Medical School, Dana-Farber Cancer Institute
Matthew G. Vander Heiden, MD, PhD Massachusetts Institute of Technology
Adrian Vella, MD Mayo Clinic
Jennifer A. Wargo, MD, MMSc University of Texas M.D. Anderson Cancer Center
James C. Yao, MD University of Texas M.D. Anderson Cancer Center
Hao Zhu, MD University of Texas Southwestern Medical Center

Call for Council nominations, 2019

Posted on by John Hawley

The Society seeks nominations for the following vacancies on the ASCI Council (all terms begin and end in the spring): Vice President (4-year term, 2019-2023) and 2 Councilor positions (3-year term, 2019-2022).

All Council members are expected to support the activities of and attend the ASCI annual meeting, and to participate in the general governance of the Society, including two in-person meetings (fall and spring, coordinate with the annual meeting) and conference calls (typically every other month). All Council members participate in the review of membership nominations.

The Vice President transitions to President-Elect in year 2 and President in year 3. For the 2nd through 4th years of this position, this member is expected to participate significantly in matters related to the Joint Meeting. In the Presidential year (year 3), the member convenes a face-to-face Council meeting and oversees related review processes for nominations, notably including those to membership. The President works closely with the Association of American Physicians to create the annual meeting program, and the member presents the traditional Presidential Address at the meeting. In year 4, the President transitions to Immediate Past President, serving as an advisor to the current President and with full Council responsibilities and privileges.

The Council is supported by an Executive Director, Managing Director, and other staff members who oversee the day-to-day operations of the Society and effect initiatives as directed by the Council. For details on Officers and Councilors, see the ASCI Bylaws.

Members who will be 55 or younger in 2022 are eligible for nomination. Nominations must be submitted by members through their member accounts by January 2, 2019, at 11:59 PM Eastern, and consist of a 250-word summary of accomplishments accompanied by an NIH-style brief biosketch (PDF only). Self-nominations are not allowed. If the nomination is intended for a specific vacancy, note this in the nomination comments. The Society encourages members to consider diversity in identifying those suitable for nomination.

Call for nominations: 2019 Young Physician-Scientist Awards

Posted on by John Hawley

The ASCI is pleased to call for nominations for the ASCI’s 2019 Young Physician-Scientist Awards. This is an excellent opportunity for a young faculty member to be recognized at the 2019 Joint Meeting.

We seek nominations from ASCI members of outstanding physician-scientists who have recently received their first faculty appointment (preferably in the last 5 years).

Nominees must be funded by a current NIH K or equivalent career-development award (in or outside the United States). However, we welcome nominations of NIH intramural physician-scientists on the basis of their appointment only. See nomination form for detail.

Those selected for this Awards program will:

  • receive a $500 travel award to attend the 2019 Joint Meeting, April 5-7, at the Fairmont Chicago
  • present their work at the ASCI’s Food & Science Evening, Saturday, April 6

Up to 40 Awards will be given for 2019. The following materials are required for nominations, which must be submitted by nominating members through their accounts on or before the deadline, December 14, 2018, at 11:59 pm, U.S. Eastern (extended from December 3, 2018):

  • Nomination form: download form
    Note: For the requested abstract, it should not be submitted separately to the Joint Meeting for consideration; it should only be submitted for consideration as part of the nomination.
  • NIH-style biosketch

ASCI members elected to the National Academy of Medicine, 2018

Posted on by John Hawley

The ASCI congratulates its members who have been elected to the National Academy of Medicine for 2018. Fourteen members are represented among the 75 regular members elected for 2018 (full list). (Citation information following each member as given by the National Academy of Medicine.)

Richard S. Blumberg, MD (elected to ASCI in 1995)

For multiple seminal, paradigm-changing contributions to our understanding of mucosal immunology and immune development having identified mechanistic alterations central to several diseases, including inflammatory bowel disease, autoimmune disorders, and cancer.

Michael A. Caligiuri, MD (elected to ASCI in 1998)

For the discovery of the stages of human natural killer (NK) cell development, the role of IL-15 in NK survival, and in the pathogenesis of NK leukemia and cutaneous T cell lymphoma.

Michael S. Diamond, MD, PhD (elected to ASCI in 2007)

For research on the molecular basis and immune-mediated control of global infectious disease threats, including Zika, dengue, and chikungunya viruses, and defining critical viral determinants of the immune response that have facilitated the development of countermeasures to prevent their spread.

Susan M. Domchek, MD (elected to ASCI in 2013)

For contributions in the evaluation and management of hereditary breast and ovarian cancer including the introduction of two BRCA1/2 specific drug therapies.

Benjamin Levine Ebert, MD, PhD (elected to ASCI in 2011)

For contributions to understanding the genetics and biology of myeloid malignancies, to the characterization of clonal hematopoiesis, and to elucidating the mechanism of action of thalidomide and its analogs.

Robert M. Friedlander, MD, MA (elected to ASCI in 2006)

For demonstrating the role of caspases in cell-death pathways in neurologic diseases, and for groundbreaking discoveries that have led to the development of novel therapies to improve outcomes for patients suffering from stroke, brain and spinal cord injury, Huntington’s disease, and ALS.

William A. Gahl, MD, PhD (elected to ASCI in 1988)

For contributions that include creating the Undiagnosed Diseases Program within intramural NIH to meld individualized patient care with next-generation sequencing and to provide insights into new mechanisms of disease; spearheading expansion to the national Undiagnosed Diseases Network and the Undiagnosed Disease Network International; and championing the sharing of genetic databases and best practices.

David Allen Hafler, MD, MSc (elected to ASCI in 1993)

For seminal discoveries defining the pathogenesis of multiple sclerosis (MS), including identification of autoreactive T cells and mechanisms that underlie their dysregulation, and the discovery of susceptibility genes that lead to MS.

Steven M. Holland, MD (elected to ASCI in 2003)

For distinguished achievements in primary immunodeficiencies and infectious diseases, including the recognition, treatment, genomic identification, and cure of previously unexplained diseases as well as the identification and characterization of novel pathogens in those diseases.

Ophir David Klein, MD, PhD (elected to ASCI in 2013)

For his international reputation in developmental and stem cell biology, focusing on craniofacial, tooth, and bone development and regeneration, destined to lead to the biologically inspired restoration of teeth and other organs.

Matthew Langer Meyerson, MD, PhD (elected to ASCI in 2007)

For discovery of EGFR mutations in lung cancer and their ability to predict responsiveness to EGFR inhibitors, thereby helping to establish the current paradigm of precision cancer therapy.

Lucila Ohno-Machado, MD, PhD (elected to ASCI in 2010)

For creating an algorithm that allows sharing access to clinical data while respecting the privacy of individuals and institutions.

Jordan Scott Orange, MD, PhD (elected to ASCI in 2010)

For his research achievements in defining a new class of immune diseases, natural killer cell deficiencies, as well as other genetic immunodeficiencies.

Rachel M. Werner, MD, PhD (elected to ASCI in 2012)

For advancing our understanding of how health care provider performance measurement and incentives often bring unintended and undesired equity consequences that compete with efficiency goals.

Thank you to recent donors

Posted on by John Hawley
Visionary Innovator Advocate Benefactor Friend
$10,000 or more $5,000 or more $2,500 or more $2,500 or more up to $1,500
2017 annual appeal Korsmeyer Award Fund Seldin-Smith Award Fund Medical Fellows Initiative
Anupam Agarwal, MD Friend
David H. Alpers, MD Friend
Scott A. Armstrong, MD, PhD Friend
Andrew Arnold, MD Friend
Peter S. Aronson, MD Friend
Richard Aster, MD Friend
John P. Atkinson, MD Benefactor
Barbara J. Ballermann, MD Friend
Robert H. Baloh, MD, PhD Friend
Craig Blackstone, MD, PhD Friend
Paul Laszlo Bollyky, MD, PhD Friend
Myles Brown and Judy Garber Friend Friend
Charles C. J. Carpenter, MD Friend
Jean-Laurent Casanova, MD, PhD Friend
Lynda Chin, MD Friend
Barry S. Coller, MD Friend
Peter Crawford Friend
James E. Crowe, Jr., MD Friend
Darling Foundation Benefactor
John H. Dirks, MD Friend
Ronny I. Drapkin, MD, PhD Friend
David Drutz, MD Friend
Benjamin L. Ebert, MD, PhD Friend
Norman H. Edelman, MD Friend
Jonathan A. Epstein, MD Advocate
James A. Fagin, MD Friend
Anthony W. Ferrante, Jr., MD, PhD Friend
Andrew P. Fontenot, MD Friend
Donald E. Ganem, MD Friend
David Ginsburg, MD Friend
William B. Greenough, III, MD Friend
Karen Guth Friend
Harrington Discovery Institute Visionary
John B. Hawley Friend
Helen H. Hobbs, MD Innovator
David Hockenbery, MD Advocate
Maya Hoptman Friend
Henry N. Hulter, MD Friend
Benjamin D. Humphreys, MD, PhD Friend Friend Friend
Mukesh K. Jain, MD, FAHA Friend
Stuart Kornfeld, MD Friend
Susan Korsmeyer, Carnell Korsmeyer, and John B. Hawley Visionary
Mitchell A. Lazar, MD, PhD Friend
Brendan and Maria Lee Friend
James Lee, MD Friend
Timothy J. Ley, MD Friend
Robert W. Mahley, MD, PhD Friend
Kieren Marr, MD Friend
Donna M. Martin, MD, PhD Friend
Laura Mauri, MD, MSc Friend
Colleen McGarry Friend
Hidayatullah G. Munshi, MD Friend
David G. Nathan, MD Friend
Paul Nghiem, MD, PhD Friend
Peter A. Nigrovic, MD Friend
Scott André Oakes, MD Friend
Robert K. Ockner, MD Friend
John Erik Pandolfino, MD, MSCI Friend
Jane R. Parnes, MD Friend
Daniel Porte, Jr., MD Friend
Louis J. Ptáček, MD Friend
W. Kimryn Rathmell, MD, PhD Friend
Charles W. M. Roberts, MD Friend
Eileen Rojas Friend
Steven M. Rowe, MD, MSPH Friend
Sanjay Saint, MD, MPH Friend Friend
Charles L. Sawyers, MD Visionary
Victor L. Schuster, MD Friend
Debra A. Schwinn, MD Friend
Donald W. Seldin, MD Friend
Dolores M. Shoback, MD Friend
Gerald I. Shulman, MD, PhD Friend
Aisha Siebert Friend
Ben Z. Stanger, MD, PhD Friend
Simeon Taylor, MD, PhD Friend
University of Pittsburgh Friend
Lorraine B. Ware, MD Friend
Arthur Weiss, MD, PhD Friend
Michael A. Weiss, MD, PhD Friend
Michael J. Welsh, MD Friend
Motoko Yanagita, MD, PhD Friend

Call for nominations, 2019 Seldin~Smith Award

Posted on by John Hawley

The ASCI is pleased to call for nominations for the 2019 Donald Seldin~Holly Smith Award for Pioneering Research. The Award seeks to recognize and connect the next generation of physician-scientist leaders with the legacies of two of the ASCI’s most esteemed members, Drs. Donald W. Seldin and Lloyd H. “Holly” Smith Jr.

For the Award, the ASCI seeks nominations of outstanding physician-scientists who have demonstrated exceptional creativity and accomplishments in biomedical research. The ideal nominee:

  • is an early-stage, clinically active physician-scientist addressing fundamental questions that relate to human health and disease, and
  • shows great promise in biomedicine.

The recipient of the Seldin~Smith Award will receive an unrestricted grant of $30,000 to advance academic efforts. S/he will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, deliver a research talk at the 2020 Joint Meeting, and receive mentoring from the members of the Seldin~Smith Award Selection Committee and Advisory Committee.

Eligibility

  • MD (or the equivalent) or MD/PhD;
  • The candidate should be more than 2 years but not more than 6 years from first faculty (or the equivalent) appointment at the time of acceptance in April 2019;
  • The candidate spends substantial time in research while providing direct patient care.

This competition is not restricted to any geographic location.

Application

Physician-scientists should apply directly by sending nominations by email attachments to staff@the-asci.org.

  • Completed nomination form, including:
    • a summary of the nominee’s research (not to exceed 100 words)
    • a description of the nominee’s most significant achievement (not to exceed 500 words).
    • a list of the nominee’s three most significant publications and a short statement describing the significance of each publication (not to exceed 100 words each).
    • Nominee’s agreement, if chosen as the recipient, to attend the 2019 AAP/ASCI/APSA Joint Meeting (April 5-7) and the 2020 AAP/ASCI/APSA Joint Meeting (April 3-5).
  • PDFs of the nominee’s three most significant publications as listed in the nomination form.
  • Nominee’s curriculum vitae. Include only educational background, major awards, and peer-reviewed publications (do not include abstracts, grants, or meeting presentations).
  • No more than two letters of support (as PDFs), one from the nominee’s primary mentor, the other ideally from an individual who is a recognized expert on the subject of the nominee’s research.

Notable dates and selection process

  • Nomination deadline: October 29, 2018.
  • Recipient will be notified by early 2019.
  • Recipient will be recognized at the 2019 AAP/ASCI/APSA Joint Meeting, April 5-7.
  • Recipient will deliver a research talk at the 2020 AAP/ASCI/APSA Joint Meeting, April 3-5.

The Seldin~Smith Award Selection Committee reviews nominations and selects finalists for further consideration. Finalists are reviewed by the Seldin~Smith Award Advisory Committee.

About the ASCI

Founded in 1908, the ASCI is home to physician-scientist leaders in academic medicine and industry across the world. The ASCI seeks to support the scientific efforts, educational needs, and clinical aspirations of physician-scientists to improve human health. The Society, based in the United States, is a nonprofit 501(c)(3) organization.

Call for nominations, 2019 Stanley J. Korsmeyer Award

Posted on by John Hawley

Nominations for the ASCI’s 2019 Stanley J. Korsmeyer Award are now open. The recognition, first called the ASCI Award, was renamed in 2006 in honor of Dr. Korsmeyer, the first recipient of the Award in 1998, who passed away in 2005. The Korsmeyer Award recognizes individuals for their advancement of knowledge in a specific field and mentoring of future generations of life science researchers. Information on all past honorees is available here.

Nominees for the Stanley J. Korsmeyer Award must be ASCI members who are 55 years of age or younger as of January 1, 2019. They shall have made significant contributions to biomedical science and shall have adhered to the principles of scientific excellence that the ASCI exemplifies. The nominee should have a record that reflects high standards of intellectual integrity, a deep and abiding respect for the community of biomedical scientists, and a strong commitment to mentoring the next generation of physician-scientists. Prior nominees may be re-nominated. However, current ASCI Council members and prior Award recipients may not be nominated.

Nominations consist of:

  • a summary of the nominee’s accomplishments (in plain text, not to exceed 250 words),
  • a brief NIH biosketch (as a PDF),
  • a full curriculum vitae, including all publications and invited lectures (as a PDF),
  • and a trainee table (preferred as a PDF).

Nominations must be submitted by ASCI members through their online accounts.

The deadline for nominations is October 11, 2018, at 11:59 PM Eastern (extended from October 8).

Call for applications, JCI Insight Editor, 2019-2024

Posted on by John Hawley

The American Society for Clinical Investigation (ASCI) seeks an Editor in Chief to lead JCI Insight. The journal was launched in 2016 to support the ASCI’s mission of publishing impactful biomedical research, along with the Journal of Clinical Investigation (JCI).

About the Journal

JCI Insight is a peer-reviewed journal dedicated to the publication of research in all biomedical specialties, ranging from preclinical to clinical studies. While JCI Insight is complementary to the JCI, and both journals are governed by ASCI policies, the Editors and their boards are independent. JCI Insight draws submissions directly and considers submissions previously evaluated by the JCI and other journals. The journal, which the ASCI self-publishes along with the JCI, is online only and freely available to all readers and is supported by publication fees.

Duties of the Editor

The Editor is responsible for: determining the scientific content of JCI Insight; ensuring the quality and integrity of publications; assembling and leading an editorial board to handle research submissions; and meeting goals set by the ASCI Council and Publications Committee.

The selected candidate will have responsibilities that include service on the Council. The term of office is 5 years and begins September 2019.

Eligibility of the Editor and Editorial Board

To be considered for the position of Editor, a candidate must:

  • be a member of the ASCI
  • demonstrate a strong scientific track record

For the proposed Editorial Board:

  • At least two-thirds of the proposed board must be ASCI members (active or senior) in good standing
  • Multi-institution applications are encouraged

Application timeline

  • October 31, 2018: Letters of intent (LOI) due. Applicants submitting LOI will receive an operational overview of the ASCI and JCI Insight for use in developing full applications.
  • January 10, 2019: Full applications due.
  • March 4, 2019: Finalists for the Editor position determined.
  • April 4, 2019: Editor Selection Committee interviews finalists in Chicago.

Full application requirements

The applicant should address the following areas in 5 or fewer single-spaced pages:

  • Describe your vision for the scientific scope of manuscripts published in the journal under your leadership, including scientific areas you see as priorities for JCI Insight and areas you see as opportunities for growth.
  • Provide details of any proposed editorial board members. Describe how you will ensure that the team has the breadth to handle submissions across all specialties and ranging from basic research to clinical trials and bioinformatics.
  • Describe how the proposed board will evaluate manuscripts and specific efforts to ensure scientific rigor, fair decisions, and timeliness. Additionally, comment on the criteria your board will use to select suitable articles to invite for transfer from the JCI to JCI Insight.
  • Describe how you will ensure that JCI Insight complements rather than competes with the JCI in the ASCI family of journals.
  • In the event that you cannot complete the duration of the term, describe the process by which a candidate to replace the Editor would be identified (subject to approval by the Council and a vote by the membership).

In addition, the application must include a letter from each proposed Board member stating a commitment to the role.

Submitting letters of intent and applications

Address materials to Kieren Marr, MD, Chair, Editor Selection Committee, and send as an attachment to staff@the-asci.org.

Questions

Contact Sarah Jackson, Executive Editor, at sarah.jackson@insight.jci.org.

Review of applications

An Editor Selection Committee will review applications, interview candidates, and recommend a selection to the ASCI Council, which then submits the recommendation to a vote of the Active segment of the ASCI membership.

Editor Selection Committee

Chair

Kieren Marr, MD
Johns Hopkins University School of Medicine

Members

Rexford S. Ahima, MD, PhD
Johns Hopkins University School of Medicine

Hossein Ardehali, MD, PhD
Northwestern University Feinberg School of Medicine

Serpil C. Erzurum, MD
Cleveland Clinic

Andrew P. Fontenot, MD
University of Colorado School of Medicine

Sarah Jackson, PhD (non-voting)
Executive Editor

Chaim Putterman, MD
Albert Einstein College of Medicine of Yeshiva University

W. Kimryn Rathmell, MD, PhD
Vanderbilt University School of Medicine

Howard A. Rockman, MD
Duke University School of Medicine

Vijay Shah, MD
Mayo Clinic

Lorraine B. Ware, MD
Vanderbilt University School of Medicine

Nominations for 2019 membership

Posted on by John Hawley

Nominations for 2019 membership may be submitted through September 10, 2018. Proposers and supporters of nominations should review the Membership Nomination Guide carefully. Questions regarding nominations should be sent by email to staff@the-asci.org.

Note to submitters: The ASCI sends acknowledgment of submissions by email after they have been reviewed and found to be complete. Submitters can check the status of their submissions (nominations and support forms) online by accessing their member accounts.

Submitting nominations

To ensure proper tracking of nominations, all information and documents must be supplied online.
  • First, access your member account
  • After you have logged in to your account, select the “Nominations” tab, then search the nominee database. Links will appear in search results to guide you in the next steps.
  • Your nominee may already be in the ASCI database because the nominee was previously nominated or because a nomination or support form has been started for the nominee for this nomination cycle.

Proposers: Once you have supplied the requested information about your nominee (name, contact information, etc.), you will be able to upload required documents. You will also be able to add Seconder and General Supporter information to the nomination, although supporters will need to supply their comments via their own member accounts.

Seconder and General Supporters: Forms may be drafted and submitted online after selecting the applicable nominee from search results or after adding requested information about the nominee you are supporting. (NOTE: General Supporters who are not ASCI members may complete the nomination support template and email it to staff@the-asci.org for handling. Please indicate clearly your contact information and the name and institution of the nominee you are supporting.)

Further clarification

  • Age criterion for Active and Foreign Associate nominees. Nominees in these categories must be age 50 or younger as of January 1, 2019.
  • Exceptions to the age criterion cannot be made. Although the ASCI Council understands that a nominee’s progress may have been delayed because of unavoidable or extreme circumstances, the Council has on multiple occasions discussed exceptions and concluded from each discussion that no policy could be implemented fairly and durably.
  • Limit on number of nominations per nominee. The number of nominations per nominee is limited to 3, provided the nominee is age 50 as of January 1, 2019.
  • Limit on number of nominations proposed, seconded, or supported. There is no limit to the number of nominations a member may propose or support (either as Seconder or General Supporter).
  • Ph.D.-only candidates. Active and Foreign Associate nominations are, per the ASCI’s bylaws, restricted to physicians.
  • M.D.-equivalent candidates are eligible for nomination.
  • Faculty appointment versus nominee’s country of residence. The distinction between Active and Foreign Associate nominations is made on the basis of residence, not faculty appointment. Active nominees must reside in the U.S. or Canada. Candidates residing elsewhere should be nominated in the Foreign Associate category.